MSB 3.83% $1.13 mesoblast limited

"He has broken the mould for strategic behaviour and thinking by...

  1. 3,692 Posts.
    lightbulb Created with Sketch. 353
    "He has broken the mould for strategic behaviour and thinking by anyone in the life sciences in Australia. He has had at least four new investigational new drug applications passed through the FDA [US Food and Drug Administration]. No other Australian company has done that and had that success rate. That is a sign of the capability within the company, and of its consultants.”It typically takes 12 to 15 years to take any new medicine from the lab bench to the chemist’s shelf."

    By David Blake, of Bioshares
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.045(3.83%)
Mkt cap ! $1.290B
Open High Low Value Volume
$1.18 $1.19 $1.12 $12.16M 10.69M

Buyers (Bids)

No. Vol. Price($)
8 50650 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.14 124897 8
View Market Depth
Last trade - 16.10pm 08/05/2024 (20 minute delay) ?
Last
$1.13
  Change
-0.045 ( 4.33 %)
Open High Low Volume
$1.17 $1.17 $1.12 1447014
Last updated 15.59pm 08/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.